Pulmonary Mycosis in Immunocompromised Hosts

Shigeru Kohno, Kohtaro Mitsutake, Haruko Matsuda, Ken Ichi Tanaka, Shigefumi Maesaki, Kazuyoshi Kawakami, Akira Yasuoka, Takashige Miyazaki, Mitsuo Kaku, Hironobu Koga, Kohei Hara

Research output: Contribution to journalArticlepeer-review


Pulomonary mycosis, which has been diagnosed pathologically by autopsy, can also be diagnosed. clinically by serological and mycological examination. Pulmonary cryptococcosis, being characterised by its clinical features, has revealed the importance of capsular polysaccharide the pathogenesis, and the importance of macrophages and lymphocytes as host defence mechanisms. Molecular biology has been adapted to diagnostic usage. Pulmonary aspergillosis has been increasing in spite of the development of antifungal agents. Both pulmonary aspergillosis and pulmonary candidiasis are difficult to diagnose clinically; their pathological features are described here. The possibility of clinical diagnosis by serology is discussed.

Original languageEnglish
Pages (from-to)295-301
Number of pages7
JournalJapanese Journal of Medical Mycology
Issue number3
Publication statusPublished - 1993 Jul


  • pulmonary aspergillosis
  • pulmonary candidiasis
  • pulmonary cryptococcosis

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases


Dive into the research topics of 'Pulmonary Mycosis in Immunocompromised Hosts'. Together they form a unique fingerprint.

Cite this